TFPI Antikörper (AA 101-200) (Alexa Fluor 647)

Produktnummer ABIN917450

Produktdetails anti-TFPI Antikörper (Alexa Fluor 647)

Target: TFPI (Tissue Factor Pathway Inhibitor (Lipoprotein-Associated Coagulation Inhibitor) (TFPI))

Bindungsspezifität: AA 101-200

Reaktivität: Ratte, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser TFPI Antikörper ist konjugiert mit Alexa Fluor 647

Applikation: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Kreuzreaktivität: Maus, Ratte

Homologie: Human,Cow,Pig,Horse,Rabbit

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human TFPI

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Haltbarkeit: 12 months

Details zu TFPI

Target: TFPI (Tissue Factor Pathway Inhibitor (Lipoprotein-Associated Coagulation Inhibitor) (TFPI))

Andere Bezeichnung: Tfpi/Laci (TFPI Produkte)

Synonyme: EPI antikoerper, LACI antikoerper, TFI antikoerper, TFPI1 antikoerper, A630013F22Rik antikoerper, AW552122 antikoerper, TFPI antikoerper, si:dz44f8.1 antikoerper, tfpib antikoerper, wu:fb92g01 antikoerper, zgc:152844 antikoerper, zgc:158592 antikoerper, tissue factor pathway inhibitor antikoerper, tissue factor pathway inhibitor a antikoerper, TFPI antikoerper, Tfpi antikoerper, tfpia antikoerper

Hintergrund:

Synonyms: EPI, TFI, LACI, TFPI1, Tissue factor pathway inhibitor, TFPI, Extrinsic pathway inhibitor, Lipoprotein-associated coagulation inhibitor

Background: Inhibits factor X (X(a)) directly and, in a Xa-dependent way, inhibits VIIa/tissue factor activity, presumably by forming a quaternary Xa/LACI/VIIa/TF complex. It possesses an antithrombotic action and also the ability to associate with lipoproteins in plasma.

Gen-ID: 7035

UniProt: P10646